Evidence method
Level · gp.fundamentals.debt_to_revenue
170.66% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
HBIO · Jun 30, 2025
HARVARD BIOSCIENCE INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001171843-25-005287General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.44% · OPTIONAL · VALID
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
13.47% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
-11.46% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
108.83% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
56.40% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-4.00% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
10.70% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
2.31% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History16 statesHistory building
Sep 30, 20220/8 normalizedLevel 3Dec 31, 20220/8 normalizedLevel 3Mar 31, 20230/8 normalizedLevel 3Jun 30, 20230/8 normalizedLevel 3Sep 30, 20230/9 normalizedLevel 3Dec 31, 20230/9 normalizedLevel 3Mar 31, 20240/9 normalizedLevel 3Jun 30, 20240/9 normalizedLevel 3Sep 30, 20248/9 normalizedLevel 3Dec 31, 20248/9 normalizedLevel 3Mar 31, 20258/9 normalizedLevel 3Jun 30, 20258/9 normalizedLevel 3Sep 30, 20259/9 normalizedLevel 3Dec 31, 20259/9 normalizedLevel 3Mar 31, 20269/9 normalizedLevel 3Jun 30, 20269/9 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 167.17%
- Current
- 170.66%
- Delta
- 3.49%
- Previous
- 2.36%
- Current
- 0.44%
- Delta
- -1.92%
- Previous
- 13.71%
- Current
- 13.47%
- Delta
- -0.24%
- Previous
- -11.17%
- Current
- -11.46%
- Delta
- -0.29%
- Previous
- 104.79%
- Current
- 108.83%
- Delta
- 4.04%
- Previous
- 55.96%
- Current
- 56.40%
- Delta
- 0.44%
- Previous
- -228.11%
- Current
- -4.00%
- Delta
- 224.10%
- Previous
- 10.66%
- Current
- 10.70%
- Delta
- 0.04%
- Previous
- 2.76%
- Current
- 2.31%
- Delta
- -0.45%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · HBIO Fundamental State →Has State · HARVARD BIOSCIENCE INC →Transitioned To · HBIO Fundamental State →Transitioned To · HBIO BALANCE_SHEET_LEVERAGE_INCREASED →Transitioned To · HBIO CAPEX_INTENSITY_DECREASED →Transitioned To · HBIO CASH_GENERATION_DECREASED →Transitioned To · HBIO GROWTH_DECREASED →Transitioned To · HBIO INVENTORY_PRESSURE_INCREASED →Transitioned To · HBIO MARGIN_INCREASED →Transitioned To · HBIO PROFITABILITY_INCREASED →Transitioned To · HBIO R_AND_D_INTENSITY_INCREASED →Transitioned To · HBIO SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.